PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"PARP (Poly ADP‐Ribose Polymerase) Inhibitors for Locally Advanced or Metastatic Breast Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436565/0/Autoinflation_for_hearing_loss_associated_with_otitis_media_with_effusion:_Cochrane_systematic_review. Accessed 29 March 2024.
PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436565/0/Autoinflation_for_hearing_loss_associated_with_otitis_media_with_effusion:_Cochrane_systematic_review. Accessed March 29, 2024.
PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436565/0/Autoinflation_for_hearing_loss_associated_with_otitis_media_with_effusion:_Cochrane_systematic_review
PARP (Poly ADP‐Ribose Polymerase) Inhibitors for Locally Advanced or Metastatic Breast Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436565/0/Autoinflation_for_hearing_loss_associated_with_otitis_media_with_effusion:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer
ID - 436565
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436565/0/Autoinflation_for_hearing_loss_associated_with_otitis_media_with_effusion:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -